Boston Scientific left nursing its bottom line after cyberattack

Boston Scientific says that last month's cyberattack caused enough disruption that it is unlikely to meet its sales growth and adjusted earnings guidance for either the third quarter or the full year. The medical device giant disclosed the expected financial hit in an SEC filing published Tuesday, two weeks after an intrusion knocked systems...